Investors on TrustBills are determined to continue investing in trade receivables even during the Corona crisis. For this reason, we do not expect the purchase volume on TrustBills to disappear or decrease.
For companies, the sale of receivables via TrustBills offers an ideal alternative and addition to the classic working capital loan (and other loans or state aid).
Selling your B2B invoices on TrustBills will shorten your balance sheet, increase your equity ratio and improve your credit rating. And you can even support your customers' liquidity situation by extending their payment terms. This extension is possible when selling receivables on TrustBills without your company losing liquidity itself.
After invoicing, you can sell your invoices immediately on TrustBills at your minimum price conditions. Unlike many factoring programs, there is no obligation to offer - you define yourself to what extent and under what conditions you want to use TrustBills.
Please do not hesitate to contact us if you have any further questions about the effects of the Corona crisis on our marketplace.
Selling Trade Receivables via TrustBills is more advantageous than factoring, supply chain finance programs or dynamic discounting. Auction off your unpaid B2B invoices in an undisclosed or disclosed way and receive the purchase price immediately — without any security retentions, credit insurance and framework contracts. And always at market price.
Trade receivables offer short durations and high Sharpe Ratios due to low volatilities and low correlation toward other asset classes. TrustBills' automatization replaces relatively expensive securitization, making trade receivables both economical and easy to acquire for institutional investors.
Joerg Hoerster, Founder of TrustBills
Tim Cook, CEO of Apple Inc.